LEGN

Legend Biotech Corporation

Price

$19.98

return (12m)

-41.87%

p/e

-42.74

p/bv

3.18

DIVIDEND YIELD

0.00%

LEGN price

Legend Biotech

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LEGN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

5.66%

3 months

-26.44%

1 year

-41.87%

2 years

-64.74%

5 years

-47.46%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals LEGN

Valuation

P/E

-42.74

Sector -4.26

Industry -4.26

P/BV

3.18

Sector 2.11

Industry 2.11

P/Revenue (PSR)

3.08

Sector 2.08

Industry 2.08

EV/EBITDA

40.43

Sector -546.19

Industry -546.19

EV/EBIT

48.14

Sector -37.31

Industry -37.31

P/EBITDA

342.29

Sector -50.76

Industry -50.76

P/EBIT

-115.65

Sector -39.62

Industry -39.62

P/Total Assets

2.24

Sector 1.25

Industry 1.25

P/Net Current Assets

5.55

Sector -5.47

Industry -5.47

P/Working Capital

4.75

Sector -1.10

Industry -1.10

EPS

-0.49

Sector -1.94

Industry -1.94

BVPS

6.58

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

56.57%

Sector 38.90%

Industry 38.90%

EBITDA Margin

18.84%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

15.82%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-4.42%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-7.21%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.22

Sector 0.03

Industry 0.03

Profitability

ROE

-7.45%

Sector -61.50%

Industry -61.50%

ROA

-5.23%

Sector -63.85%

Industry -63.85%

ROIC

18.51%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.04

Sector 2.89

Industry 2.89

Net Debt / EBITDA

-13.21

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

-15.74

Sector -10.24

Industry -10.24

Net Debt / Equity

-0.78

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.70

Sector 0.43

Industry 0.43

Liabilities/Assets

0.30

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

87.31%

Sector -

Industry -

5Y Earnings CAGR

-26.01%

Sector -

Industry -

Fundamentals LEGN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LEGN Legend Biotech Corporation	$19.98	-42.45%	0.00%	-42.74	3.18	-7.45%	-7.21%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LEGN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Legend Biotech

Legend Biotech Corporation

Average Investor10 user rating

4.0 (1 people)

United States

11 years

Founded: 2015

2020

Time since IPO - 6 years

882

Employees

Legend Biotech Corporation (United States) is listed on the Nasdaq and has a market capitalization of $3.92 billion, with shareholders equity totaling $1.23 billion.

The company employs approximately 882 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Legend Biotech Corporation reported $1.27 billion in revenue, generating net income of $-91.61 million.

Key financial metrics include a P/E ratio of -42.74, a price-to-book (P/B) ratio of 3.18, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LEGN.

Market cap

$3.92 billion

Net worth

$1.23 billion

$1,229,600,000.00

Assets

$1.75 billion

$1,750,900,000.00

Total Shares Outstanding

187.00 million

187,000,000

Average Daily Trading Volume

$2.60 million

$2,603,155.82

Sector

Health Care

Industry

Biotechnology

LEGN

LEGN revenue and profits

Financial Results LEGN

DRAG THE FRAME TO SEE MORE DATA

LEGN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Legend Biotech (LEGN) today?

A cotação de Legend Biotech (LEGN) hoje está em US$ 19.98, com uma variação de -41.87% em relação ao último ano. A cotação de Legend Biotech (LEGN) iniciou o ano negociando na casa dos US$ 21.74 e hoje está em US$ 19.98. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Legend Biotech (LEGN) e dados de ações do Ibovespa e mercados internacionais.

Quando Legend Biotech (LEGN) paga dividendos?

Legend Biotech (LEGN) não distribuiu dividendos no último ano.

Is Legend Biotech (LEGN) a good investment?

Atualmente, Legend Biotech (LEGN) está cotada a US$ 19.98, com um P/L de -42.74, representando um desvio de -2,616% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -41.87 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -41.87%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Legend Biotech (LEGN) stock?

Investir em ações de Legend Biotech (LEGN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Legend Biotech (LEGN) yield today?

A rentabilidade de Legend Biotech (LEGN) foi de 5.66% no último mês, -41.87% no último ano e -47.46% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Legend Biotech (LEGN) hoje, o investimento total seria de US$ 1,998.00, com base na cotação atual de US$ 19.98.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,161.44
Em 5 anos: US$ 1,049.75
Em 10 anos: US$ 1,998.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LEGN

Legend Biotech Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LEGN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING LEGN WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Legend Biotech

Legend Biotech Corporation

United States

11 years

2020

882

PROFIT X PRICE LEGN

Financial Results LEGN

LEGN cash flow

Asset, Revenue and Profit Growth - LEGN

LEGN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions